Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.33 |
| ▸ | GRM3 | Q14832 | 2/20 | 0.33 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.33 |
| ▸ | MAOB | P27338 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | GRM8 | O00222 | 1/20 | 0.33 |
| ▸ | GRM6 | O15303 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | GRM5 | P41594 | 1/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.33 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.33 |
| ▸ | PLCB1 | Q9NQ66 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL224980 | 1.00 | APLNR (0.58) | APLNRCYP2C19CYP1A2ALOX15ALDH1A1 | |
| SCHEMBL6567505 | 0.86 | TSHR (0.44) | APLNRCYP2C19CYP1A2ALOX15ALDH1A1 | |
| SCHEMBL416167 | 0.81 | APLNR (0.58) | APLNRCYP2C19CYP1A2ALOX15ALDH1A1 | |
| SCHEMBL12110903 | 0.81 | APLNR (0.58) | APLNRCYP2C19CYP1A2ALOX15ALDH1A1 | |
| SCHEMBL7178038 | 0.81 | APLNR (0.36) | APLNRMAOB | |
| SCHEMBL15568682 | 0.80 | APLNR (0.42) | APLNRCYP2C19CYP1A2ALOX15ALDH1A1 | |
| SCHEMBL3741325 | 0.79 | SMN1; SMN2 (0.36) | APLNRMAOBTDP1 | |
| SCHEMBL15951391 | 0.79 | APLNR (0.56) | APLNRCYP2C19CYP1A2ALOX15ALDH1A1 | |
| SCHEMBL6173752 | 0.76 | APLNR (0.52) | APLNRCYP2C19CYP1A2ALOX15ALDH1A1 | |
| SCHEMBL17586693 | 0.76 | APLNR (0.52) | APLNRCYP2C19CYP1A2ALOX15ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8329158-B2 | Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2012-12-11 | — | — | US | disclosed |
| US-20110274733-A1 | POLYMERS CONTAINING POLY(HYDROXYALKANOATES) AND AGENTS FOR USE WITH MEDICAL ARTICLES AND METHODS OF FABRICATING THE SAME | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2011-11-10 | — | — | US | disclosed |
| US-20110274695-A1 | PRODRUGS CONTAINING NOVEL BIO-CLEAVABLE LINKERS | PIRAMAL LIFE SCIENCES LIMITED | 2011-11-10 | — | — | US | disclosed |
| US-20110269709-A1 | PRODRUGS CONTAINING NOVEL BIO-CLEAVABLE LINKERS | PIRAMAL LIFE SCIENCES LIMITED | 2011-11-03 | — | — | US | disclosed |
| US-20110269722-A1 | PRODRUGS CONTAINING NOVEL BIO-CLEAVABLE LINKERS | Piramal Life Science Limited | 2011-11-03 | — | — | US | disclosed |
| US-20110268690-A1 | POLYMERS CONTAINING POLY(HYDROXYALKANOATES) AND AGENTS FOR USE WITH MEDICAL ARTICLES AND METHODS OF FABRICATING THE SAME | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2011-11-03 | — | — | US | disclosed |
| US-8007775-B2 | Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2011-08-30 | — | — | US | disclosed |
| US-7932294-B2 | Prodrugs containing novel bio-cleavable linkers | APPARAO SATYAM (IN) | 2011-04-26 | — | — | US | disclosed |
| EP-2269657-A2 | Prodrugs containing novel bio-cleavable linkers | Piramal Life Sciences Limited (IN) | 2011-01-05 | — | — | EP | disclosed |
| US-7361726-B2 | Poly(hydroxyalkanoate-co-ester amides) and agents for use with medical articles | ADVANCED CARDIOVASCULAR SYSTEMS INC. (US) | 2008-04-22 | — | — | US | disclosed |
| EP-1851263-A1 | POLY(HYDROXYALKANOATE-CO-ESTER AMIDES) AND AGENTS FOR USE WITH MEDICAL ARTICLES | Abbott Cardiovascular Systems, Inc. (US) | 2007-11-07 | — | — | EP | disclosed |
| EP-1846476-A1 | POLYMERS CONTAINING POLY(HYDROXYALKANOATES) AND AGENTS FOR USE WITH MEDICAL ARTICLES AND METHODS OF FABRICATING THE SAME | Abbott Cardiovascular Systems, Inc. (US) | 2007-10-24 | — | — | EP | disclosed |
| US-20070149724-A1 | Poly(hydroxyalkanoate-co-ester amides) and agents for use with medical articles | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2007-06-28 | — | — | US | disclosed |
| US-7202325-B2 | Poly(hydroxyalkanoate-co-ester amides) and agents for use with medical articles | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2007-04-10 | — | — | US | disclosed |
| WO-2006078356-A1 | POLY(HYDROXYALKANOATE-CO-ESTER AMIDES) AND AGENTS FOR USE WITH MEDICAL ARTICLES | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2006-07-27 | — | — | WO | disclosed |
| US-20060160985-A1 | POLY(HYDROXYALKANOATE-CO-ESTER AMIDES) AND AGENTS FOR USE WITH MEDICAL ARTICLES | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2006-07-20 | — | — | US | disclosed |
| WO-2006073631-A1 | POLYMERS CONTAINING POLY(HYDROXYALKANOATES) AND AGENTS FOR USE WITH MEDICAL ARTICLES AND METHODS OF FABRICATING THE SAME | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2006-07-13 | — | — | WO | disclosed |
| US-20060147412-A1 | Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2006-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110269722-A1 | PRODRUGS CONTAINING NOVEL BIO-CLEAVABLE LINKERS | SI, UGT1A1, CYP2B6 | APLNR 2637/4885CYP2C19 5/4885CYP1A2 33/4885 |
| US-20110274695-A1 | PRODRUGS CONTAINING NOVEL BIO-CLEAVABLE LINKERS | SI, UGT1A1, CYP2B6 | APLNR 2637/4885CYP2C19 5/4885CYP1A2 33/4885 |
| US-20110268690-A1 | POLYMERS CONTAINING POLY(HYDROXYALKANOATES) AND AGENTS FOR USE WITH MEDICAL ARTICLES AND METHODS OF FABRICATING THE SAME | LIPA, PUF60, CD68 | APLNR 2739/4885CYP2C19 3368/4885CYP1A2 3404/4885 |
| US-20060147412-A1 | Polymers containing poly(hydroxyalkanoates) and agents for use with medical articles and methods of fabricating the same | PUF60, PLOD3, HGF | APLNR 3016/4885CYP2C19 2095/4885CYP1A2 2200/4885 |
| US-20110274733-A1 | POLYMERS CONTAINING POLY(HYDROXYALKANOATES) AND AGENTS FOR USE WITH MEDICAL ARTICLES AND METHODS OF FABRICATING THE SAME | PUF60, CCL11, TLR3 | APLNR 1617/4885CYP2C19 3030/4885CYP1A2 3008/4885 |
| US-20110269709-A1 | PRODRUGS CONTAINING NOVEL BIO-CLEAVABLE LINKERS | SI, UGT1A1, CYP2B6 | APLNR 2637/4885CYP2C19 5/4885CYP1A2 33/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.